BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, July 21, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Sep. 19, 2018

View Archived Issues

Archimedes shows promise in virtually diagnosing lung tumors outside main airways

Broncus Medical Inc., of San Jose, Calif., is highlighting data that it says shows that the Archimedes virtual bronchoscopy navigation system significantly improves access to solitary pulmonary nodules (SPN). The company noted that the system helps increase the diagnostic yield for nodules without a bronchus sign or an airway leading to the nodule. The data were unveiled at the European Respiratory Society (ERS) International Congress being held in Paris this week. Read More

Cook blasts FDA for ban of special 510(k)s in biliary stent draft

Read More

Atacor team raises $8.8M to develop pacemaker that doesn't touch heart

Read More

Cognetivity gets patent OK for Alzheimer's test as clinical trial for ICA platform set to begin

HAMBURG, Germany – Cognetivity Neurosciences Ltd. has received "two key patent application approvals" from the U.S. and from the EU for its Integrated Cognitive Assessment (ICA) platform, a test for early detection of signs of Alzheimer's disease. "Securing patents in key markets for our technology is a major company milestone and something we've worked very hard to achieve," said Cognetivity's CEO Sina Habibi. "This protection of our unique and innovative technology puts us in a strong position as we move through the final stages of the regulatory process, finalize our clinical product and launch a commercial product within these territories." Read More

Microbiome not getting its due in the development of precision medicine

Read More

Financings

Read More

Appointments and advancements

Read More

Daily M&A

Read More

Product briefs

Read More

Other news to note

Read More

BioWorld MedTech's Oncology Extra

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 20, 2026.
  • ALN-5288 lowers tau levels in preclinical models

    BioWorld Science
    Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
  • International currency symbols

    Capital remains selective in ‘barbell’ biotech market

    BioWorld
    Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
  • Neuropathy illustrated in legs and feet

    LIT-002 is strong candidate for autism and neuropathic pain

    BioWorld Science
    Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
  • Silhouette of head and brainwith fractal art

    ATAI-dyed Lilly tees up in psychedelics, finds $3.8B fit

    BioWorld
    Rumblings that psychedelic treatments would soon be ready for prime time gained credence aplenty, and shares of Ataibeckley Inc. (NASDAQ:ATAI) ended July 16 at...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing